{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:01:26Z","timestamp":1783537286348,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009294","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T00:00:00Z","timestamp":1326844800000}}],"reference-count":47,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009294.pub2","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T17:34:38Z","timestamp":1326908078000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Intravesical gemcitabine for non-muscle invasive bladder cancer"],"prefix":"10.1002","author":[{"given":"Gabriel","family":"Jones","sequence":"first","affiliation":[{"name":"Research Department, Velindre NHS Trust; Cochrane Prostatic Diseases and Urological Cancers Unit; Cardiff Wales UK CF14 2TL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cleves","sequence":"additional","affiliation":[{"name":"Cardiff University Velindre Hospital; Cancer Research Wales Library; Cardiff Wales UK CF14 2TL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"Wilt","sequence":"additional","affiliation":[{"name":"VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Mason","sequence":"additional","affiliation":[{"name":"Velindre Hospital; Clinical Oncology; Whitchurch Cardiff UK CF4 7XL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard G","family":"Kynaston","sequence":"additional","affiliation":[{"name":"Cardiff University; Department of Surgery; Heath Park Cardiff Wales UK CF14 4XN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Shelley","sequence":"additional","affiliation":[{"name":"Velindre NHS Trust; Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept; Velindre Road Whitchurch Cardiff Wales UK CF4 7XL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,18]]},"reference":[{"key":"10.1002\/14651858.CD009294.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2008.20.8199","article-title":"Randomised phase III trial on Gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance","volume":"28","author":"Addeo","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Bendary L Khalil S Shahin A Nawar N Intravesical gemcitabine versus bacillus Calmette-Guerin (BCG) in treatment of non-muscle invasive bladder cancer: Short term comparative study Conference Proceedings American Urological Association 2011 e664 5","DOI":"10.1016\/j.juro.2011.02.1765"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.eururo.2009.06.010","article-title":"Single postoperative instillation of gemcitabine in patients with non-muscle invasive transitional cell carcinoma of the bladder: A randomised, double-blind, placebo controlled phase III multicentre study","volume":"56","author":"Bohle","year":"2009","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.urology.2005.03.084","article-title":"Randomised phase II marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent stage Ta urothelial cell carcinoma of the bladder","volume":"66","author":"Gardmark","year":"2005","journal-title":"Urology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/cncr.24914","article-title":"Gemcitabine versus Bacille Calmette-Guerin after initial Bacille Calmette-Guerin failure in non-muscle invasive bladder cancer","volume":"116","author":"Lorenzo","year":"2010","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000273461","article-title":"Bacillus Calmette-Guerin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: A randomised prospective study","volume":"84","author":"Porena","year":"2010","journal-title":"Urologia Internationalis"},{"issue":"4","key":"10.1002\/14651858.CD009294.pub2-BIB0007|cit7","first-page":"283","article-title":"Gemcitabine versus BCG after initial BCG failure in non-muscle invasive bladder cancer:A prospective randomised trial","volume":"8","author":"Autorino","year":"2009","journal-title":"24th Congress of the European Association of Urology, Stockholm"},{"issue":"4","key":"10.1002\/14651858.CD009294.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.urology.2005.04.062","article-title":"Intravesical gemcitabine therapy for superficial transitional cell carcinoma: Results of a phase II multicentre study","volume":"66","author":"Bartoletti","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1002\/14651858.CD009294.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1569-9056(05)80878-4","article-title":"Adjuvant intravesical gemcitabine in intermediate or high risk transitional cell carcinoma of the bladder: a multicentre prospective trial","volume":"4","author":"Bartoletti","year":"2005","journal-title":"European Urology Suplements"},{"issue":"4 suppl S","key":"10.1002\/14651858.CD009294.pub2-BIB0010|cit10","first-page":"698","article-title":"Single postoperative instillation of gemcitabine in patients with superficial transitional cell carcinoma of the bladder: a randomised, double-blind, placebo controlled phase 3 multicentre study","volume":"181","author":"Boehle","year":"2009","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1002\/14651858.CD009294.pub2-BIB0011|cit11","first-page":"897","article-title":"Single postoperative instillation of gemcitabine in patients with non-muscle invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo controlled phase III multicentre study","volume":"184","author":"Boehle","year":"2010","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD009294.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0022-5347(09)61930-3","article-title":"Single postoperative instillation of gemcitabine in patients with superficial transitional cell carcinoma of the bladder; A randomised double-blind, placebo controlled phase 3 multicentre study","volume":"181","author":"Bohle","year":"2009","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD009294.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1177\/147323000903700618","article-title":"The effects of intravesical chemoimmunotherapy with gemcitabine and bacillus Calmette-Guerin in superficial bladder cancer: a preliminary study","volume":"37","author":"Cho","year":"2009","journal-title":"Journal of International Medical Research"},{"issue":"14","key":"10.1002\/14651858.CD009294.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejcsup.2008.06.049","article-title":"Intravesical gemcitabine versus mitomycin for recurrent superficial bladder tumours (stages pTa and pT1): a randomised prospective trial","volume":"6","author":"Faiola","year":"2008","journal-title":"EJC Supplements"},{"issue":"Suppl 214","key":"10.1002\/14651858.CD009294.pub2-BIB0015|cit15","first-page":"42","article-title":"A phase II study evaluating the effect of intravesical gemzar (R) in recurrent superficial transitional cell carcinoma of the bladder: initial results","volume":"37","author":"Gardmark","year":"2003","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0016|cit16","first-page":"400","article-title":"The effect of different dose regimes in intravesical treatment of urinary bladder cancer with gemcitabine: a randomised phase II marker study","volume":"Abstract","author":"Gardmark","year":"2005","journal-title":"Proceedings of the American Society of Clinical Oncology"},{"issue":"16","key":"10.1002\/14651858.CD009294.pub2-BIB0017|cit17","first-page":"Abstract 400S","article-title":"The effect of different dose regimes in intravesical treatment of urinary bladder cancer with gemcitabine: a randomised phase II marker tumour study","volume":"23","author":"Gardmark","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD009294.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1569-9056(05)80874-7","article-title":"Will a more intensive scheduling of gemcitabine (R) improve chemoablation in recurrent urinary bladder cancer? A randomised phase II marker lesion study","volume":"4","author":"Gardmark","year":"2005","journal-title":"European Urology Supplememts"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0019|cit19","unstructured":"Hadley AM Lynch W Nash P Phase II trial of intravesical gemcitabine in patients with urothelial carcinoma of the bladder Proceedings of the American Society of Clinical Oncology 2008 Abstract 335"},{"issue":"4","key":"10.1002\/14651858.CD009294.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4111\/kju.2008.49.4.313","article-title":"Initial experience on intravesical gemcitabine instillation followed by bacillus Calmette-Guerin (BCG) therapy for treating intermediate or high risk patients with superficial bladder cancer","volume":"49","author":"Kim","year":"2003","journal-title":"Korean Journal of Urology"},{"issue":"part 1","key":"10.1002\/14651858.CD009294.pub2-BIB0021|cit21","first-page":"268","article-title":"Intravesical gemcitabine versus mitomycin for recurrent superficial bladder tumours (stages pTa and pT1) : A randomised prospective study","volume":"15S","author":"Montella","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD009294.pub2-BIB0022|cit22","first-page":"1","article-title":"Multicentre study on the use of gemcitabine to prevent recurrence of multiple-recurring superficial bladder tumours following intravesical antiblastic agents and\/or BCG: evaluation and tolerance","volume":"78","author":"Morabito","year":"2006","journal-title":"Archivo Italiano di Urologia Andrologia"},{"issue":"2","key":"10.1002\/14651858.CD009294.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.eururo.2010.11.009","article-title":"Re: Randomised Phase III trial on gemcitabine versus mitomycin in recurrent superficial bladder cancer: Evaulation of efficacy and tolerance","volume":"59","author":"Rampersaud","year":"2011","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.urology.2005.04.062","article-title":"Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a phase II prospective multicentre study","volume":"66","author":"Bartoletti","year":"2005","journal-title":"Urology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0025|cit25","unstructured":"Cancer Research UK Blader Cancer http\/info.cancerresearchuk.org\/cancerstats\/types\/bladder (Accessed May 2011)"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1200\/JCO.2005.05.2720","article-title":"Phase II trial of intravesical gemcitabine in Bacille Galmette-Guerin refractory transitional cell carcinoma of the bladder","volume":"24","author":"Dalbagni","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD009294.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0094-0143(03)00060-0","article-title":"Evaluation and follow-up strategies for superficial bladder cancer","volume":"30","author":"Donat","year":"2003","journal-title":"Urological Clinics of North America"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.eururo.2004.05.001","article-title":"A phase II study to investigate the ablative efficacy of intravesical administration of gemcitabine in intermediate risk superficial bladder cancer","volume":"46","author":"Gontero","year":"2004","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/bmj.308.6923.257","article-title":"Proposed changes for cystoscopic follow-up in patients with bladder cancer and adjuvant intravesical chemotherapy","volume":"308","author":"Hall","year":"1994","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-5347(05)67972-4","article-title":"Tumour progression and survival of patients with high grade, non-invasive papillary (TaG3) bladder tumors: 15-year outcome","volume":"163","author":"Herr","year":"2000","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0031|cit31","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 The Cochrane Collaboration,"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0032|cit32","first-page":"43","article-title":"Cancer Statistics","volume":"57","author":"Jemal","year":"2007","journal-title":"CA: Cancer Journal for Clinicians"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001813-200207000-00002","article-title":"Selective cytotoxicity of gemcitabine in bladder cancer cell lines","volume":"13","author":"Kilani","year":"2002","journal-title":"Anticancer Drugs"},{"issue":"11","key":"10.1002\/14651858.CD009294.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/0959-8049(95)00287-S","article-title":"Factors affecting recurrence and progression in superficial bladder cancer","volume":"23A","author":"Kurth","year":"1995","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2003.09.028","article-title":"Intravesical gemcitabine therapy for superficial transitional cell carcinoma: a phase I and pharmacokinetic study","volume":"21","author":"Laufer","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","article-title":"Multivariate analysis of the prognostic factors of primary superficial bladder cancer","volume":"163","author":"Millan-Rodriguez","year":"2000","journal-title":"Journal of Urology"},{"issue":"supplement 5","key":"10.1002\/14651858.CD009294.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/annonc\/mdj941","article-title":"Cellular pharmacology of gemcitabine","volume":"17","author":"Mini","year":"2006","journal-title":"Annals of Oncology"},{"issue":"supplementum","key":"10.1002\/14651858.CD009294.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/03008880802285032","article-title":"Global burden of urinary bladder cancer","volume":"218","author":"Parkin","year":"2008","journal-title":"Scandinavian Journal of Urology & Nephrology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0039|cit39","article-title":"Beyond BCG: Gemcitabine","volume-title":"Current Clinical Urology: Bladder Cancer. Eds CT Lee & DP Wood","author":"Raj","year":"2010"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.urology.2004.08.027","article-title":"Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder: Phase I-II study on marker lesions","volume":"65","author":"Serretta","year":"2005","journal-title":"Urology"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1464-410x.2001.02306.x","article-title":"A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer","volume":"88","author":"Shelley","year":"2001","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1464-410X.2003.04655.x","article-title":"Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomised trials","volume":"93","author":"Shelley","year":"2004","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ctrv.2009.12.005","article-title":"Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses","volume":"36","author":"Shelley","year":"2010","journal-title":"Cancer Treatment Reviews"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"Art No: CD00897","DOI":"10.1002\/14651858.CD008976.pub2","article-title":"Gemcitabine for unresectable, locally advanced or metastatic bladder cancer","volume":"4","author":"Shelley","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009294.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using the EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"European Urology"},{"issue":"2","key":"10.1002\/14651858.CD009294.pub2-BIB0046|cit46","first-page":"5835","article-title":"Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract","volume":"58","author":"Takahashi","year":"1998","journal-title":"Cancer Research"},{"issue":"4","key":"10.1002\/14651858.CD009294.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0090-4295(00)01053-0","article-title":"Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies","volume":"5","author":"Zaak","year":"2001","journal-title":"Urology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009294.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009294.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:31:03Z","timestamp":1628533863000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009294.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Urology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,1,18]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009294.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14161956.15663056","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,18]]}}}